Patricia E. Greenstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galactosemias | 2 | 2020 | 125 | 0.780 |
Why?
|
| Neurites | 1 | 2020 | 388 | 0.640 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2737 | 0.320 |
Why?
|
| Dementia | 1 | 2020 | 2518 | 0.270 |
Why?
|
| Brain Mapping | 2 | 2020 | 6670 | 0.250 |
Why?
|
| Machado-Joseph Disease | 2 | 2012 | 26 | 0.250 |
Why?
|
| Interferon-beta | 1 | 2006 | 324 | 0.240 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2004 | 243 | 0.220 |
Why?
|
| Vision, Monocular | 1 | 2023 | 78 | 0.220 |
Why?
|
| Retinal Artery Occlusion | 1 | 2023 | 74 | 0.220 |
Why?
|
| Tick Paralysis | 1 | 2002 | 2 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 1000 | 0.180 |
Why?
|
| Transverse Sinuses | 1 | 2019 | 24 | 0.170 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 8038 | 0.170 |
Why?
|
| Huntington Disease | 1 | 2004 | 1124 | 0.150 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2019 | 145 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2006 | 1253 | 0.150 |
Why?
|
| Myotonic Dystrophy | 1 | 1997 | 78 | 0.150 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1996 | 43 | 0.140 |
Why?
|
| Anisotropy | 1 | 2020 | 1265 | 0.140 |
Why?
|
| Ataxia | 1 | 2018 | 304 | 0.130 |
Why?
|
| Cerebellar Diseases | 1 | 2018 | 226 | 0.130 |
Why?
|
| Mosaicism | 1 | 1997 | 441 | 0.120 |
Why?
|
| Muscular Diseases | 1 | 2019 | 555 | 0.120 |
Why?
|
| Catheterization | 1 | 2019 | 1470 | 0.110 |
Why?
|
| Cerebellar Ataxia | 1 | 2013 | 145 | 0.100 |
Why?
|
| Motor Activity | 2 | 2020 | 2715 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2019 | 1951 | 0.100 |
Why?
|
| Multiple Sclerosis | 1 | 2006 | 3079 | 0.100 |
Why?
|
| Language | 1 | 2020 | 1471 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1524 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 290 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 271 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2108 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 326 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2011 | 494 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 6994 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4925 | 0.070 |
Why?
|
| Cerebellum | 1 | 2013 | 1488 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 1980 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2020 | 6151 | 0.060 |
Why?
|
| Liver Function Tests | 1 | 2006 | 528 | 0.060 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2013 | 1433 | 0.060 |
Why?
|
| Dermacentor | 1 | 2002 | 1 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2004 | 798 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21748 | 0.050 |
Why?
|
| Myoglobinuria | 1 | 2000 | 23 | 0.050 |
Why?
|
| North America | 1 | 2004 | 1249 | 0.050 |
Why?
|
| Prednisone | 1 | 2006 | 1574 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1378 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1641 | 0.050 |
Why?
|
| Japan | 1 | 2004 | 1360 | 0.050 |
Why?
|
| Electron Transport Complex IV | 1 | 2000 | 189 | 0.050 |
Why?
|
| Adult | 9 | 2020 | 214052 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2002 | 621 | 0.040 |
Why?
|
| Genotype | 3 | 2011 | 12952 | 0.040 |
Why?
|
| Blindness | 1 | 2023 | 615 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2023 | 940 | 0.040 |
Why?
|
| Humans | 17 | 2023 | 744366 | 0.040 |
Why?
|
| Male | 9 | 2020 | 350115 | 0.040 |
Why?
|
| Female | 12 | 2023 | 380193 | 0.040 |
Why?
|
| Embryonic Induction | 2 | 1995 | 149 | 0.040 |
Why?
|
| Age of Onset | 1 | 2004 | 3270 | 0.040 |
Why?
|
| Gait | 2 | 2013 | 793 | 0.040 |
Why?
|
| Pedigree | 1 | 2004 | 4642 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 261 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1997 | 209 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 56429 | 0.030 |
Why?
|
| Aged | 5 | 2023 | 163288 | 0.030 |
Why?
|
| Mesoderm | 2 | 1995 | 686 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2000 | 817 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 11366 | 0.030 |
Why?
|
| Catalepsy | 1 | 1993 | 34 | 0.030 |
Why?
|
| Acute Disease | 1 | 2023 | 7147 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1851 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2616 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12961 | 0.030 |
Why?
|
| Zebrafish Proteins | 2 | 1995 | 1005 | 0.030 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2011 | 68 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1993 | 635 | 0.020 |
Why?
|
| Eye | 1 | 1995 | 729 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 2657 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1997 | 1640 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1997 | 1357 | 0.020 |
Why?
|
| Liver | 1 | 2006 | 7475 | 0.020 |
Why?
|
| Proteins | 2 | 1995 | 6100 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 780 | 0.020 |
Why?
|
| Electromyography | 1 | 2013 | 1379 | 0.020 |
Why?
|
| Phenotype | 3 | 2011 | 16367 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9981 | 0.020 |
Why?
|
| Middle Aged | 6 | 2019 | 213390 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15535 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2013 | 63107 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1993 | 1011 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7882 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1997 | 1887 | 0.020 |
Why?
|
| Zebrafish | 2 | 1995 | 2996 | 0.020 |
Why?
|
| Neonatal Screening | 1 | 2011 | 591 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1995 | 1703 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2019 | 5984 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1995 | 2926 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2011 | 25628 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2006 | 23336 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 39052 | 0.010 |
Why?
|
| Affect | 1 | 2012 | 1475 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 57776 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 3617 | 0.010 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1061 | 0.010 |
Why?
|
| DNA Primers | 2 | 1995 | 2891 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 769 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12025 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8861 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 29786 | 0.010 |
Why?
|
| Notochord | 1 | 1995 | 36 | 0.010 |
Why?
|
| Muscles | 1 | 2000 | 1614 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13286 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 12797 | 0.010 |
Why?
|
| Animals | 3 | 2002 | 168768 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 13814 | 0.010 |
Why?
|
| Xenopus | 1 | 1995 | 712 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 9240 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 18111 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1993 | 265 | 0.010 |
Why?
|
| Hemianopsia | 1 | 1993 | 122 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1995 | 751 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1993 | 393 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1950 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 1995 | 721 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2839 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2256 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 1995 | 783 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 931 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1995 | 1364 | 0.010 |
Why?
|
| Recurrence | 1 | 2000 | 8340 | 0.010 |
Why?
|
| Brain | 1 | 1995 | 26388 | 0.010 |
Why?
|
| Posture | 1 | 1993 | 958 | 0.000 |
Why?
|
| Drosophila | 1 | 1995 | 1491 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13693 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 6171 | 0.000 |
Why?
|
| Adolescent | 1 | 2011 | 85779 | 0.000 |
Why?
|
| Gene Expression | 1 | 1995 | 7798 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1993 | 5709 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1993 | 35425 | 0.000 |
Why?
|